Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment

The development of chemoresistance in human pancreatic cancer is one reason for the poor survival rate for patients with this cancer. Because multiple gene products are linked with chemoresistance, we investigated the ability of ursolic acid (UA) to sensitize pancreatic cancer cells to gemcitabine,...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Sahdeo, Yadav, Vivek R., Sung, Bokyung, Gupta, Subash C., Tyagi, Amit K., Aggarwal, Bharat B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914350/
https://www.ncbi.nlm.nih.gov/pubmed/26909608
http://dx.doi.org/10.18632/oncotarget.7537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914350/
https://www.ncbi.nlm.nih.gov/pubmed/26909608
http://dx.doi.org/10.18632/oncotarget.7537

Ejemplares similares